Echelon lowers price target on Nubeva Technologies, keep buy rating

Echelon Wealth Partners analyst Gianluca Tucci thinks there is a ton of upside to be had in Nubeva Technologies (Nubeva Technologies Stock Quote, Chart TSXV:NBVA), but the analyts’s most recent report has him tempering expectations slightly.

In a research update to clients Wednesday, Tucci maintained his “Speculative Buy” rating, but lowered his one-year price target on Nubeva from $1.50 to $1.20, implying a return of 243 per cent at the time of publication.

The analyst explained his reasoning.

“We are bullish on the company’s pivot to focus on Prisms ahead of StratusEdge,” Tucci said. “We believe that this will lead to incremental longer term shareholder gains. However, we have tempered our near term momentum expectations as we wait for the prisms to gain customer trials and more importantly commercial adoption. In the context of a TSXV that declined 35% for 2018 and with an applicable ~20% discount rate within DCF valuations, we are reducing our PT by 20% to C$1.20 reflecting timing considerations and looking for visibility on a ramp in commercial revenues.”

Tucci thinks Nubeva will post Adjusted EBITDA of negative $1.4-million (all figures USD) on revenue of $2.4-million in fiscal 2019. He expects those numbers will improve to EBITDA of negative $200,000 on a topline of $1.9-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: nbva
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

8 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

18 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

20 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

1 day ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

2 days ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

2 days ago